Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P589 | DOI: 10.1530/endoabs.32.P589

ECE2013 Poster Presentations Female reproduction (47 abstracts)

The assessment of metabolic derangements including metabolic syndrome in relation to the degree of hyperandrogenism in women with polycystic ovary syndrome

Jelica Bjekic-Macut 1 , Ivana Bozic Antic 2 , Dimitrios Panidis 3 , Danijela Vojnovic Milutinovic 4 , Olivera Stanojlovic 5 , Milan Petakov 2 , Bojana Popovic 2 , Tamara Bogavac 2 , Sanja Ognjanovic 2 , Tatjana Isailovic 2 , Valentina Elezovic 2 , Dusan Ilic 2 & Djuro Macut 2


1Clinical-Hospital Center “Bežanijska kosa”, Belgrade, Serbia; 2Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 3Division of Endocrinology and Human Reproduction, 2nd Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece; 4Institute for Biologic Investigations “Siniša Stanković”, Belgrade, Serbia; 5Institute for Physiology, Medical Faculty, University of Belgrade, Belgrade, Serbia.


Introduction: Polycystic ovary syndrome (PCOS) is associated with a higher risk for development of metabolic syndrome (MS). In this study, we evaluated the degree of metabolic disorders in women with PCOS and different degree of hyperandrogenism (HA).

Methods: We analyzed 234 women with PCOS (group PCOS; BMI: 22.4±3.6 kg/m2, age: 24.8±4.7 years) diagnosed on the basis of ESHRE/ASRM criteria, and 45 healthy BMI-matched women who comprised the control group (group controls; BMI: 21.3±3.2 kg/m2, age: 28.3±4.9 years). Women with PCOS were divided into three subgroups according to the presence of HA: i) with biochemical HA (n=123), ii) with clinical HA (n=61), and iii) without clinical or biochemical HA (n=50). In all subjects, basal blood samples were collected in follicular phase of menstrual cycle for determination of glucose, insulin, total cholesterol (TC), HDL, LDL, triglycerides, apolipoproteins A1, A2, B and E, lipoprotein(a), C-reactive protein (CRP) and uric acid. HOMA index was calculated using standard formula, and lipid ratios TC/HDL, LDL/HDL, triglycerides/HDL, ApoB/ApoA1 were determined. MS was diagnosed according to JIS criteria.

Results: In comparison to PCOS subgroup B and C, PCOS subgroup A had higher triglycerides (P<0.001 and P=0.012) and CRP (P=0.032 and P=0.022), lower ApoA1 (P=0.045 and P=0.007), and higher TC:HDL ratio (P=0.02 and P=0.007) and triglycerides:HDL ratio (P<0.001 and P=0.001), respectively. PCOS subgroup A in comparison to PCOS subgroup C had significantly lower HDL (P<0.001) and higher ApoB:ApoA1 ratio (P=0.045). There was higher prevalence of MS in PCOS subgroup A (21%) in comparison to groups B (3%) and C (3%), P<0.001.

Conclusion: PCOS women with biochemical HA had unfavorable lipid profile and higher prevalence of MS than PCOS women without hyperandrogenemia.

Article tools

My recent searches

No recent searches.